Florida U.S. Senator Marco Rubio (R) cited the most recent undercover investigation released by Project Veritas (PV) in a letter to Albert Bourla, CEO of Pfizer, and noted that, according to the PV video, Pfizer may be conducting gain-of-function research to mutate the COVID virus to create additional variants and vaccines to combat them for profit. Rubio’s office noted that, in the PV exposé, Pfizer executive Jordon Trishton Walker claimed the drug company is considering the possibility of mutating the COVID virus itself via “directed evolution” in order to keep profiting off a continued stream of vaccines – which he later said would be a “cash cow” for the company.Read More
A top-level Pfizer executive revealed to an undercover Project Veritas (PV) journalist that the pharmaceutical giant is considering the possibility of mutating the COVID virus itself via “directed evolution” in order to keep profiting off a continued stream of vaccines. Following the release of the first video, which was published Wednesday, Jordon Trishton Walker, Pfizer director of Research and Development, Strategic Operations – mRNA Scientific Planner, is seen in a second video assaulting PV founder James O’Keefe and his staff in a restaurant, and destroying the iPad showing the undercover video recordings.Read More
Wall Street Journal (WSJ) editorial board member Allysia Finley took to task both the federal government and the pharmaceutical giants profiting from the sale of their COVID mRNA booster shots for a “deceptive advertising” push for Americans to continue taking boosters without proof of their safety or effectiveness. The U.S. Department of Health and Human Services (HHS) and its health and regulatory agencies are engaged in a “deceptive advertising” campaign, wrote Finley Sunday, suggesting the pressure tactics “shouldn’t come as a surprise,” since the federal government “took the unprecedented step of ordering vaccine makers to produce them and recommending them without data supporting their safety or efficacy.”Read More
Less than a month after the CDC marked the two-year anniversary of the first administered COVID-19 vaccine by telling Americans to get a bivalent booster, two peer-reviewed German studies have found that mRNA vaccines — the vast majority of the U.S. market — induce worse antibodies compared to traditional adenovirus vaccines. The first paper, published in Science Immunology Dec. 22, focused on mRNA boosters, while the second, published in Frontiers in Immunology Jan. 12, found the same association with the two-dose primary series.Read More
Nearly two years after their mRNA “vaccines” were released to the public, both Pfizer and Moderna are finally conducting clinical trials to track long-term adverse health effects following a diagnosis of vaccine-associated myocarditis and pericarditis in teens and young adults under the age of 21. Myocarditis can cause permanent damage to heart muscle and even death.Read More
Pfizer Inc. and BioNTech announced Wednesday the Biden Food and Drug Administration (FDA) granted Emergency Use Authorization (EUA) for their “bivalent” mRNA COVID-19 booster shot for children aged 5-11 years without having completed clinical trials.
“As families across the country take part in fall festivities and plan for the upcoming holiday season, we aim to provide school-aged children with additional protection against the Omicron BA.4/BA.5 subvariants, which continue to account for more than 80% of cases in the U.S.,” said Pfizer CEO Albert Bourla. “Anticipating this need, we manufactured millions of booster doses, which will be made available, pending CDC recommendation, to help families stay up to date with COVID-19 vaccinations.”Read More
A top Pfizer international executive admitted to a European Parliament committee Tuesday that the pharmaceutical giant did not test its COVID mRNA shot for whether it could prevent transmission of the virus before it was placed on the market and then mandated in many parts of society throughout the world.
Rob Roos, a member of the European Parliament from the Netherlands, tweeted a video of his exchange with Janine Small, president of international developed markets at Pfizer.Read More
Drug giant Pfizer says its top-level “Breakthrough Fellowship Program” that prohibits whites and Asians from applying is a “Bold Move” that promotes “a more inclusive workplace,” and will have Pfizer led by “a new generation” of minority fellows by 2025.
“One of Pfizer’s Bold Moves is to create a workplace for all, and we are committed to increasing diversity by fostering a more inclusive workplace,” says Pfizer, one of the Big Pharma companies at the center of the controversial COVID-19 vaccines.Read More
Moderna is filing patent infringement lawsuits against Pfizer and BioNTech in U.S. district court and German regional court Friday in connection with the two companies’ COVID-19 vaccine, Moderna announced.
Moderna alleges Pfizer and BioNTech’s Comirnaty vaccine breaches its mRNA technology patents submitted between 2010 and 2016. It claims they developed their vaccine by copying the technology Moderna used to make its mRNA COVID-19 vaccine, Spikevax.Read More
More than 40 percent of pregnant women who participated in Pfizer’s mRNA COVID vaccine trial suffered miscarriages, according internal Pfizer documents, recently released under court order. Despite this, Pfizer, and the Biden administration insisted that the vaccines were safe for pregnant women. Out of 50 pregnant women, 22 of them lost their babies, according to an analysis of the documents.Read More
White House Senior adviser Anita Dunn has consulted for companies and trade groups that have benefited or stand to benefit from federal funding and is being forced to recuse herself from matters involving them, according to a financial disclosure.
Dunn has consulted through the public affairs firm SKDK during the past two years for the likes of Pfizer, AT&T, Micron and the American Clean Power Association, according to a filing reported on by CNBC Friday. Dunn, who founded the SKDK in 2004, is recused from working on issues related to past clients, a spokesman for the White House told the Daily Caller News Foundation.Read More
As the nation’s most powerful and twice-boosted infectious disease doctor battles a COVID-19 “rebound” two weeks after testing positive, new research from the public health schools at Harvard and Yale suggests the boosted fared worse against the first Omicron subvariant than the non-boosted.
The FDA is so alarmed by the “waning effectiveness” of boosters, whose formulation is still based on the ancestral Wuhan strain, that it asked manufacturers Thursday to add a “spike protein component” from the fourth and fifth Omicron subvariants to this fall’s boosters.Read More
A peer-reviewed paper released on Friday shows large decreases in sperm counts among men after the second dose of Pfizer’s mRNA COVID vaccine, with the decline continuing for over five months in many cases.
The study, published in the medical journal Andrology, confirms that the mRNA shots have significant fertility risks for men, independent journalist Alex Berenson reported on his Unreported Truths Substack.Read More
Pfizer has asked a U.S. court to throw out a whistleblower’s lawsuit on the basis that the company can’t be guilty of fraud, abuse, and protocol violations in its COVID Vaccine clinical trials because its contract with the U.S. government allowed them to skirt regulations and federal laws that typically apply to government contracts.Read More
A doctor “crashed” a Food and Drug Administration’s meeting with outside vaccine experts earlier this week, to share a whistleblower’s story about the data integrity issues that plagued one of Pfizer’s clinical trials.
In September of 2020, a researcher from an organization testing Pfizer’s vaccine at several sites in Texas, emailed a complaint to the FDA, informing the agency of the company’s dangerously shoddy research practices. The FDA took no action on her email, and Pfizer continues to use the company.Read More
Pfizer hired 1,800 additional full-time employees in the first half of 2021 to deal with “the large increase” of adverse reactions to its COVID vaccine, newly released secret documents reveal. The Pfizer-BioNTech COVID-19 Vaccine was made available under the Emergency Use Authorization (EUA) on Dec. 11, 2020. By February of 2021, the company was seeing so many safety signals, including in pregnant and breastfeeding mothers, it had to immediately hire 600 employees to process the data.Read More
On Sunday, the chief executive officer of Pfizer said that Americans should be prepared to receive a second booster shot of the Coronavirus vaccine, which would mark the fourth overall shot that has been forced on the American public.
As reported by Politico, Albert Bourla made his remarks in an interview with CBS’ Margaret Brennan, where he said that his company was preparing to submit “a significant package of data about the need for a fourth dose” to the Food and Drug Administration (FDA).Read More
Researchers are churning out biased studies promoting medical gender transitions for children, often supported by pharmaceutical companies and activist organizations, and the media frequently promotes the conclusions uncritically.
A March 2021 National Institute for Health and Care Excellence comprehensive review of nine studies failed to find evidence that hormonal therapy and puberty blockers were helpful. The review pointed out common flaws in transgender treatment research, such as confounding variables and bias resulting from observational studies that lack control groups.Read More
The messenger RNA from Pfizer’s COVID-19 vaccine reportedly can enter human liver cells and be converted into DNA, contrary to what the CDC has said.Read More
The National Institutes of Health (NIH) Thursday declined to comment recently revealed revelations that Pfizer is not currently shipping its fully Food and Drug Administration (FDA) approved vaccine called Comirnaty in the United States.
Instead, Pfizer continues to ship – and healthcare providers continue to distribute – the Pfizer BioNTech vaccine, which has only received Emergency Use Authorization (EUA) approval from the FDA.Read More
Twitter late Thursday acknowledged that Just the News founder and Editor-in-Chief John Solomon’s account was “suspended in error” this week over a post about a COVID-19 vaccine.
The respond follows an appeal earlier in the day by Solomon after his account was suspended Tuesday for his tweet linking to the article “Pfizer to continue distributing version of COVID-19 vaccine not fully approved by FDA.”Read More
The Centers for Disease Control and Prevention has updated the amount of time it recommends people isolate themselves after testing positive for COVID-19, shortening it from 10 days to five.
“Given what we currently know about COVID-19 and the Omicron variant, CDC is shortening the recommended time for isolation from 10 days for people with COVID-19 to 5 days, if asymptomatic, followed by 5 days of wearing a mask when around others,” the CDC said in a statement Monday.
The CDC changed the guidance because officials believe the data indicates the majority of COVID-19 transmission takes place early in the course of the illness, “generally in the 1-2 days prior to onset of symptoms and the 2-3 days after,” the statement said.Read More
Just a day after taking the Moderna booster shot, a New York Times editor unexpectedly died of a heart attack.
“This is Carlos’s wife, Nora. It’s with deepest sorrow that I have to share with you that Carlos passed away last night of a heart attack. I’ve lost my best friend and our kids lost a truly great dad. I will be off social media for awhile,” Carlos Tejada’s wife announced on his Twitter account on Dec. 18.Read More
New York-based Pfizer has sold and shipped hundreds of millions of doses of its Food and Drug Administration (FDA) approved COVID-19 vaccine Comirnaty to the European Union (EU) despite saying last week that it is not being shipped in the United States.
“Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced they will supply an additional 100 million doses of COMIRNATY®, the companies’ COVID-19 vaccine, to the 27 European Union (EU) member states in 2021,” Pfizer said in an April press release. “This announcement is a result of the European Commission’s (EC) decision to exercise its option to purchase an additional 100 million doses under its expanded Advanced Purchase Agreement signed on February 17, 2021. This brings the total number of doses to be delivered to the EU to 600 million.”Read More
Through Ohio attorneys representing Miami University in a lawsuit against the school over its mandatory COVID-19 vaccine policy, The Ohio Star confirmed that at least none batches of Pfizer’s Emergency Use Authorization (EUA) vaccine were deemed Biologics License Application (BLA) compliant.
BLA compliance is typically reserved for Food and Drug Administration (FDA) approved drugs. That is the licensing procedure for drugs seeking to become FDA approved.Read More
Of the three companies producing COVID vaccines in the U.S., only one—Pfizer Inc.—has yet gained full FDA approval, and at least some Pfizer vaccines currently being administered in Pennsylvania come from inventory that predates that approval.
On Aug. 23, the U.S. Food and Drug Administration (FDA) approved a Pfizer shot to prevent severe COVID-19 cases. Like Johnson & Johnson and Moderna, Pfizer had been a manufacturing vaccine to fight the coronavirus under federal emergency-use authorization (EUA). The injection produced by Pfizer under EUA is known as Pfizer BioNTech and the company’s post-FDA approval vaccine is called Comirnaty (pronounced kuh-MUR-nit-ee).Read More
The majority opinion released on Friday by the 6th Circuit Court of Appeals, which restored the Biden administration’s Occupational Safety and Health Administration (OSHA) Emergency Temporary Standard (ETS) requiring employers with more than 100 employees to mandate that all employees take a COVID-19 vaccinefalsely asserts that Pfizer’s Food and Drug Administration (FDA) fully approved vaccine is currently available and in use among the general public.”
“At the same time, the options available to combat COVID-19 changed significantly: the FDA granted approval to one vaccine on August 23, 2021, and testing became more readily available,” the majority opinion asserts on page 24 of the ruling.
The majority opinion was written by Obama-appointed Judge Jane Branstretter Stranch of the United States Court of Appeals for the Sixth Circuit.Read More
A Kentucky congressman Saturday said that Pfizer’s Food and Drug Administration (FDA) approved COVID-19 vaccine is not available in the United States after The Ohio Star spent a week reporting on that subject.
“Your first sentence, ‘Comirnaty is available in the US,’ is false. Show us one location it’s available to prove otherwise. The FDA requires Pfizer to disclose to other countries BioNTech is ‘subject to an EUA and is not approved or licensed by the FDA,'” Rep. Thomas Massie (R-KY-04) said on Twitter.Read More
Last week in this space, I included a few words about Robert F. Kennedy, Jr.’s remarkable new book, The Real Anthony Fauci: Bill Gates, Big Pharma, and the Global War on Democracy and Public Health. I also included a link to Kennedy’s appearance on “Tucker Carlson Today.”
It was a remarkable exchange and I commend both the book and the interview to your attention. I disagree with Kennedy about various things, including the efficacy of vaccines in general, but his assessment of the highest-paid employee of the federal government, Anthony Fauci, is worth the price of admission.
As I remarked a couple of weeks ago, I thought I had done writing about COVID. Surely, I thought, the hysteria is on the wane. Most people are rational. They know that the flimsy porous masks you see everywhere are useless tokens of conformity. They understand that the disease is serious for only a tiny part of the population. They also know staying home and practicing “social distancing” has its own liabilities, not least of which is a diminution in the potency of one’s immune response.Read More
At least two parents have accused a prep school in South Los Angeles of vaccinating their children without their permission after bribing them with pizza, according to NBC Los Angeles. One distressed mother claimed that her 13-year-old son was told not to tell his parents after he was given a Pfizer COVID-19 injection at Barack Obama Global Prep Academy.
Maribel Duarte told NBC LA on Monday that her son recently came home from school with a vaccine card after he had accepted the jab. The boy told his mom that he agreed to get the shot after he was offered pizza. Duarte said that the woman who administered the shot and signed the form told her son not to tell his parents because she didn’t want to get in trouble.Read More
On Monday, the Food and Drug Administration (FDA) requested that the courts allow the agency to wait until the year 2076 to release all of the relevant documents regarding the approval of the vaccine developed by Pfizer and BioNTech, as reported by the Daily Caller.
The FDA made its request after a lawsuit was filed against the agency by the group Public Health Medical Professionals for Transparency (PHMPT). The PHMPT had previously made a Freedom of Information Act (FOIA) request on September 9th asking for the release of the vaccine approval documents; after the FDA denied the request, the group filed its lawsuit on September 16th.
The FDA concluded that there were roughly 329,000 pages in total that would qualify under this FOIA request. In its appeal to the courts, the agency said that, at most, employees would be able to “process and produce the non-exempt portions of responsive records at a rate of 500 pages per month.” Under this process, the FDA said that it would hand over prioritized documents to the plaintiff, and release non-exempt documents on a “rolling basis.”Read More
The Food and Drug Administration (FDA) approved Moderna and Pfizer’s COVID-19 vaccines for booster shot use for adults in the U.S., the agency announced Friday,
The announcement was made just two months after the FDA first rejected the White House’s plan to administer booster shots to all adults the week of Sept. 20. FDA Acting Commissioner Janet Woodcock approved the booster without holding the usual public meeting to review the data, and the Centers for Disease Control and Prevention (CDC) will meet Friday afternoon to discuss the authorization, according to the FDA press release.
“Throughout the course of the COVID-19 pandemic, the FDA has worked to make timely public health decisions as the pandemic evolves. COVID-19 vaccines have proven to be the best and highly effective defense against COVID-19,” Woodcock said in the press release.Read More